{"id":559633,"date":"2026-07-24T23:06:50","date_gmt":"2026-07-24T21:06:50","guid":{"rendered":"https:\/\/medizinonline.com\/traitement-systemique-chez-les-patients-presentant-des-comorbidites-quelle-est-la-meilleure-option\/"},"modified":"2026-07-24T23:06:57","modified_gmt":"2026-07-24T21:06:57","slug":"traitement-systemique-chez-les-patients-presentant-des-comorbidites-quelle-est-la-meilleure-option","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/traitement-systemique-chez-les-patients-presentant-des-comorbidites-quelle-est-la-meilleure-option\/","title":{"rendered":"Traitement syst\u00e9mique chez les patients pr\u00e9sentant des comorbidit\u00e9s : quelle est la meilleure option ?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Le psoriasis est une maladie syst\u00e9mique inflammatoire chronique souvent associ\u00e9e \u00e0 des comorbidit\u00e9s, ce dont il convient de tenir compte lors du traitement. Une attention particuli\u00e8re doit \u00eatre accord\u00e9e \u00e0 l\u2019arthrite psoriasique (PsA), aux maladies inflammatoires chroniques de l\u2019intestin (MICI), \u00e0 l\u2019ob\u00e9sit\u00e9 ainsi qu\u2019aux maladies cardiom\u00e9taboliques. Ces situations cliniques particuli\u00e8res constituent un d\u00e9fi th\u00e9rapeutique et n\u00e9cessitent une strat\u00e9gie de prise en charge individualis\u00e9e et interdisciplinaire. \u00c0 cet \u00e9gard, la directive S3 actuelle fournit, entre autres, de nombreuses recommandations pertinentes pour la pratique.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Ftraitement-systemique-chez-les-patients-presentant-des-comorbidites-quelle-est-la-meilleure-option%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le psoriasis est une maladie syst\u00e9mique inflammatoire chronique souvent associ\u00e9e \u00e0 des comorbidit\u00e9s, ce dont il convient de tenir compte lors du traitement. Une attention particuli\u00e8re doit \u00eatre accord\u00e9e \u00e0&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Ftraitement-systemique-chez-les-patients-presentant-des-comorbidites-quelle-est-la-meilleure-option%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":559634,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Le psoriasis \u00e0 l'\u00e8re de la m\u00e9decine de pr\u00e9cision  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11549,11378,11362,11527,11414,11410,11535,11505],"tags":[13407,27094,16021,67165,13750,17862,18140,83477,76895,67804,12625,67647,12410,15735,14035,26407,12604,26729,82363,12608,67793,23447],"powerkit_post_featured":[],"class_list":["post-559633","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-cardiologie","category-dermatologie-et-venerologie","category-etudes","category-gastro-enterologie-et-hepatologie","category-nutrition-fr","category-rapports-de-congres","category-rhumatologie","tag-arthrite-psoriasique","tag-bimekizumab-fr","tag-ced-fr","tag-chronisch-entzuendliche-darmerkrankungen-2-fr","tag-comorbidites-fr","tag-cosentyx-fr","tag-guselkumab-fr","tag-il-17-i-fr","tag-il-23-i-fr","tag-ilumetri-fr","tag-ixekizumab-fr","tag-medecine-de-precision","tag-obesite","tag-psa-fr","tag-psoriasis-fr-2","tag-risankizumab-fr","tag-secukinumab-fr","tag-skyrizi-fr","tag-taltz-fr","tag-therapie-systemique","tag-tildrakizumab-fr","tag-tremfya-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-23 01:24:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":559637,"slug":"terapia-sistemica-nei-pazienti-con-comorbilita-qual-e-la-scelta-migliore","post_title":"Terapia sistemica nei pazienti con comorbilit\u00e0: qual \u00e8 la scelta migliore?","href":"https:\/\/medizinonline.com\/it\/terapia-sistemica-nei-pazienti-con-comorbilita-qual-e-la-scelta-migliore\/"},"pt_PT":{"locale":"pt_PT","id":559617,"slug":"terapia-sistemica-em-doentes-com-comorbidades-qual-e-a-melhor-opcao","post_title":"Terapia sist\u00e9mica em doentes com comorbidades: qual \u00e9 a melhor op\u00e7\u00e3o?","href":"https:\/\/medizinonline.com\/pt-pt\/terapia-sistemica-em-doentes-com-comorbidades-qual-e-a-melhor-opcao\/"},"es_ES":{"locale":"es_ES","id":559146,"slug":"terapia-sistemica-en-pacientes-con-comorbilidades-cual-es-la-mejor-opcion","post_title":"Terapia sist\u00e9mica en pacientes con comorbilidades: \u00bfcu\u00e1l es la mejor opci\u00f3n?","href":"https:\/\/medizinonline.com\/es\/terapia-sistemica-en-pacientes-con-comorbilidades-cual-es-la-mejor-opcion\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=559633"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559633\/revisions"}],"predecessor-version":[{"id":561762,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559633\/revisions\/561762"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/559634"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=559633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=559633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=559633"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=559633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}